Publications by authors named "Rabel Gul"
Ecancermedicalscience
July 2024
Article Synopsis
- Nearly 90% of children and adolescents with Hodgkin lymphoma (HL) survive long-term, but about 5-30% may experience either refractory disease or relapse after initial treatment.
- A study at Indus Hospital analyzed 742 HL patients between 2013 and 2022, finding that 6.5% had relapsed and 4.7% were refractory, with a majority being diagnosed at stage IV and having a common pathology of nodular sclerosis.
- After second-line treatment, 70.8% of relapsed patients achieved complete remission, but significant treatment challenges persist in low-resource settings, including a lack of immunotherapy and stem cell transplants.
